Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co IncfiledCriticalMerck & Co Inc
Priority to FI88164ApriorityCriticalpatent/FI47108C/fi
Application grantedgrantedCritical
Publication of FI47108BpublicationCriticalpatent/FI47108B/fi
Publication of FI47108CpublicationCriticalpatent/FI47108C/fi
FI88164A1964-04-241964-04-24Menetelmä (3-aminopyratsiiniamido)guanidiinien valmistamiseksi, joilla on diureettiset ja/tai salureettiset ominaisuudet.
FI47108C
(fi)
Fremgangsmåde til fremstilling af (3,5-diamino-6-halogenpyrazinoyl)guanidin- eller (3,5-diamino-6-halogenpyrazinamido)guanidin-forbindelser eller syreadditionssalte deraf.
Fremgangsmåde til fremstilling af (3,5-diamino-6-halogenpyrazinoyl) guanidin- eller (3,5-diamino-6-halogenpyrazinamido) guanidin-forbindelser eller syreadditionssalte deraf.
Saosom mellanprodukter vid framstaellning av prostaglandiner eller prostaglandinliknande foereningar anvaendbara bicyklo(2,2,1)hept-2-en-7-syn-karbaldehyder